Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3685424 | 0.97 | NAAA (0.41) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL3682743 | 0.97 | NAAA (0.41) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL3689809 | 0.97 | NAAA (0.41) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL3678777 | 0.95 | ALDH1A1 (0.37) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL7198382 | 0.91 | NAAA (0.52) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL6553129 | 0.91 | ACHE (0.42) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL435016 | 0.89 | TSHR (0.33) | ALDH1A1TSHRFAAHACHE | |
| SCHEMBL23084724 | 0.89 | ALDH1A1 (0.47) | NAAAALDH1A1TSHRCYP3A4EPHX1 | |
| SCHEMBL11783281 | 0.89 | NAAA (0.55) | NAAAALDH1A1TSHREPHX1FAAH | |
| SCHEMBL22091902 | 0.89 | NAAA (0.55) | NAAAALDH1A1TSHREPHX1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2013240-B1 | PROCESS FOR THE PREPARATION OF CROSSLINKED NITROXIDE POLYMERS | PIOTREK CO LTD (JP) | 2017-05-31 | — | — | EP | disclosed |
| US-8492511-B2 | Process for the preparation of crosslinked nitroxide polymers | PIOTREK CO., LTD. (JP) | 2013-07-23 | — | — | US | disclosed |
| CN-101490100-B | Process for the preparation of crosslinked nitroxide polymers | PIOTREK CO LTD | 2012-08-22 | — | — | CN | disclosed |
| US-20100240858-A1 | PROCESS FOR THE PREPARATION OF CROSSLINKED NITROXIDE POLYMERS | PIOTREK CO., LTD. (JP) | 2010-09-23 | — | — | US | disclosed |
| CN-101490100-A | Process for the preparation of crosslinked nitroxide polymers | PIOTREK CO LTD (JP) | 2009-07-22 | — | — | CN | disclosed |
| EP-2013240-A1 | PROCESS FOR THE PREPARATION OF CROSSLINKED NITROXIDE POLYMERS | PIOTREK CO., LTD. (JP) | 2009-01-14 | — | — | EP | disclosed |
| US-7452921-B2 | for use in radiation curing; printing inks or varnishes; 4-Piperazinoacetophenone | SUN CHEMICAL CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| WO-2007115939-A1 | PROCESS FOR THE PREPARATION OF CROSSLINKED NITROXIDE POLYMERS | PIOTREK CO., LTD. (JP) | 2007-10-18 | — | — | WO | disclosed |
| US-20070066700-A1 | Piperazine-based sensitisers | SUN CHEMICAL CORPORATION | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066700-A1 | Piperazine-based sensitisers | H1-4, H1-5, EP300 | NAAA 3824/4885ALDH1A1 1874/4885TSHR 1286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.